Cancer Weekly articles from April 2004

Cancer Weekly archives from April 2004

"Switched-off" genes put first chink in colon cell's antitumor armor.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Johns Hopkins Kimmel Cancer Center scientists have identified a switched-off family of genes that may prove to be a significant and early dent in a colon cell's anticancer armor. The inactivated genes,...

Research explains why anticancer treatment effective for some, not others.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- A new anticancer agent, gefinitib (Iressa), recently received U.S. Food and Drug Administration (FDA) approval for patients with advanced non-small-cell lung cancer (NSCLC) after a series of clinical...

Breast biopsy specimens can be evaluated with proteomic analysis.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Researchers introduce a method of analyzing breast biopsy specimens using proteomic techniques. "Analysis of tumor samples by a proteomic technology, which combines two-dimensional gel...

Chemotherapy and HAART feasible for HIV-NHL patients.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Simultaneous chemotherapy and HAART regimens are feasible for HIV patients with non-Hodgkin lymphoma. Researchers in Italy "evaluated replication of human immunodeficiency virus (HIV) and the...

Combo of two natural toxins may be novel treatment for blood cancer.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Johns Hopkins Kimmel Cancer Center scientists have discovered why arsenic has long been a successful way to treat certain leukemias, and in the process have shown that a combination of the poison and a...

Obesity drug inhibits prostate tumor growth.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The Burnham Institute's Jeffrey Smith, PhD, has discovered that orlistat, commonly prescribed as an antiobesity drug, has a positive side effect: It inhibits cancer growth. Smith made this...

Tumor suppressor regulates mitosis by inhibiting APC-Cdc20 complex.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The tumor suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. According to published research from South Korea and the United States, "The tumor suppressor gene RASSF1A is...

Cloretazine receives Fast Track designation from FDA.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Vion Pharmaceuticals, Inc., (VION) has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for Cloretazine (VNP40101M) in relapsed or refractory acute myeloid leukemia...

Drinking well water is associated with bladder cancer in Argentina.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Study finds that the incidence of bladder cancer associated with arsenic in drinking water is lower than thought, but intake of well water long before the study was associated with an increased...

Tumor suppressor genes predict bladder cancer future.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The presence of two mutated genes in bladder cancer tumors indicates there is a high risk that the cancer will continue grow and spread, says a Baylor College of Medicine (BCM) researcher in a new...

Skeletal imaging agent approved by FDA.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Draximage, Inc., the radiopharmaceutical subsidiary of Draxis Health, Inc., (DRAX) (DAX), has received approval from the U.S. Food and Drug Administration (FDA) to produce and market a new formulation...

Hudson licenses radiosensitizer IPdR.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Hudson Health Sciences, Inc., (HHS), a biopharmaceutical company headquartered in San Francisco, California, has licensed IPdR, a radiosensitizer, from Yale University and The Research Foundation of the...

Ritonavir treatment may benefit glioblastoma patients.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Ritonavir therapy may be beneficial for glioma patients. "Glioblastoma is a therapeutic challenge as a highly infiltrative, proliferative, and resistant tumor," scientists in France explained....

Breast cancer foundation honors four leaders.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The Susan G. Komen Breast Cancer Foundation honored four leaders in the fight against breast cancer at its annual public policy luncheon on Capitol Hill. The event brought together advocates,...

Breast cancer patients switched to Aromasin more likely to remain cancer free.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Post-menopausal breast cancer patients who switched from tamoxifen to Aromasin (exemestane tablets) had a significantly reduced chance of recurrence and increased disease-free survival compared to...

Caelyx demonstrates efficacy, reduced cardiac toxicity.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Schering-Plough Europe reported that results of a randomized phase III clinical study demonstrated that Caelyx (pegylated liposomal doxorubicin hydrochloride) provided comparable efficacy in the...

Counseling and education can increase anxiety in some breast cancer patients.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- In general, counseling for women attending a familial breast cancer clinic lessened anxiety and depression and helped them have realistic expectations of the disease. According to a study from...

Epigenetic silencing of adhesion molecule ADAM23 occurs often in breast tumors.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The adhesion molecule A Desintegrin And Metalloprotease domain 23 gene (ADAM 23) may be downregulated during the progression of breast cancer, researchers say. "Altered cell adhesion is causally...

Epirubicin, vinorelbine, and cisplatin are effective in advanced breast cancer.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Combined epirubicin, vinorelbine, and cisplatin resulted in an 84% objective response rate for patients with advanced breast cancer. "Our objective was to evaluate the activity and safety of the...

First large-scale trial of genetically personalized treatment to start soon.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The first large-scale independent trial to study the role of molecular tumor signatures in breast cancer will get underway in the coming year, scientists announced on March 19, 2004, at the 4th European...

Lamivudine helps keep HBV at bay during cancer chemotherapy.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Researchers in Hong Kong have discovered a way to help prevent the reactivation of the hepatitis B virus (HBV) in women who are being treated with chemotherapy for breast cancer. Winnie Yeo, an...

Letrozole extends time to tumor progression in mouse model.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- In a mouse model of human breast cancer, the drug letrozole more effectively extends time to tumor progression than tamoxifen or various combinations and dosing schedules of tamoxifen plus letrozole....

MEP calls for European strategy in the fight against breast cancer.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The conditions necessary to lead to a 25% reduction in breast cancer mortality must be in place across Europe by 2008, a member of the European Parliament (MEP) said at the opening of the 4th European...

Male carriers of germline mutations in BRCA2 are at increased risk for cancer.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Men with BRCA2 mutations are at greater risk for cancer, especially before age 65, researchers report. "Major risks conferred by BRCA1 and BRCA2 in women are for cancers of the breast, ovary,...

Mammography may not be appropriate for some cognitively impaired women.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Degree of cognitive impairment, comorbidity, and lifespan should be considered when contemplating mammography in older women, researchers say. According to published research from the United States,...

Multidisciplinary approach to care might reduce time between diagnosis, therapy.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- A study from Canada on the elapsed time from breast cancer detection to first adjuvant therapy may help minimize intervals between steps in disease treatment. Daniel Rayson, MD, Division of Medical...

NDA filed with FDA for nanoparticle-based Abraxane.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APP, APPX) and American BioScience, Inc., (ABI) announced that ABI has completed the filing of a New Drug Application (NDA) to the U.S. Food and Drug...

New type of breast tumor might respond to prostate cancer drugs.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Scientists have discovered a new type of breast tumor that possibly could be treated with drugs similar to the ones used against prostate cancer, the 4th European Breast Cancer Conference heard March...

Older people lose out all around in breast cancer treatment and care.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Managing breast cancer in elderly patients presents particularly difficult challenges, an oncologist acknowledged. Lars Holmberg, from the Regional Oncologic Center, Uppsala, Sweden, told the 4th...

Oncologist calls for new guidelines on early reporting from clinical trials.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- A prominent breast cancer doctor is urging researchers to consider changing the guidelines that govern whether clinical trials should be stopped prematurely. She believes that current practice could...

Oncologist says disease is a public health problem in Brazil.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Breast cancer is a public health problem in Brazil: both incidence and mortality are increasing and not enough cancers are detected at an early stage, according to Jose Bines, MD, a medical oncologist...

Overexpressed VEGF[subscript]121 improves oxygenation in certain breast tumors.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Overexpressed VEGF[subscript]121 improves oxygenation in certain breast tumors. "Vascular endothelial growth factor (VEGF) is an intensively studied molecule that has significant potential, both in...

Paperwork interferes with occupational therapists' patient assessments.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- A survey of occupational therapists finds that preparing reports consumed much of their time that they could have spent assessing breast cancer patients. According to a study from England,...

Patent granted for mammary aspirate specimen cytology test.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Nastech Pharmaceutical Co., Inc., (NSTK) announced the issuance of a second U.S. patent, no. 6,689,073, entitled "Methods and Devices for Collecting, Handling and Processing Mammary Fluid Samples for...

Patients unhappy with follow-up visits to oncologists.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Women who have been treated for breast cancer find follow-up visits to their oncologists unsatisfactory and not reassuring, according to research carried out in Sweden. Ingrid Kossler, president of...

Pre-operative chemotherapy boosts breast conservation by up to 30%.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The increasing use of pre-operative chemotherapy means that 15% to 30% more breast cancer patients may now be suitable for breast conservation surgery than 10 years ago, according to a cancer...

Preoperative treatment with anastrozole reduces need for extensive surgery.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- New data presented at EBCC 2004 indicate that preoperative (neoadjuvant) treatment with anastrozole (Arimidex; AstraZeneca) results in clinically beneficial reductions in tumor volume, extending the...

Prospective trial shows modest benefit of tamoxifen after adjuvant chemotherapy.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- A long-running international trial of treating breast cancer patients with tamoxifen after adjuvant postoperative chemotherapy has shown that there seems to be a modest benefit. The researchers...

Radiotherapy increases CVD risk but to lesser degree with improvements.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- A large study in The Netherlands of breast cancer patients has confirmed that radiotherapy does increase the risk of death from cardiovascular disease, but it has also provided some reassuring findings...

Rates of conservation surgery vary widely among countries.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The rates of conservation surgery for breast cancer vary hugely among countries, data show. In France, for example, 72% of patients had breast conservation surgery (BCS), but in Poland it was only...

Results of comparison study favor exemestane for advanced disease.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The first results from the only Phase III trial to compare tamoxifen with the newer hormone treatment exemestane in advanced breast cancer shows that exemestane is safe, superior, and lengthens...

Screening efforts in Egypt yield higher detection rates.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- In Egypt, the Cairo Breast Screening Trial (CBST) has shown that when hard-to-reach women are personally invited for clinical breast screening conducted by female doctors, a high rate of breast cancers...

Study confirms conservation surgery is safe for BRCA cancers.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Women who carry the BRCA breast cancer genes can safely be offered breast conservation surgery with radiotherapy provided they are followed up for the rest of their lives. That is the conclusion of...

Study demonstrates clear survival benefit of treatment in clinical trials.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- A new study from Canada has found that breast cancer patients who were treated according to accepted standards of care or who took part in clinical trials were from 30% to 60% less likely to die from...

Study finds no link between melatonin levels and decreased cancer risk.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- No link between levels of the hormone melatonin and decreased breast cancer risk in women was found in a study conducted in the U.K. Experiments in animals have suggested that melatonin, a pineal...

Study highlights importance of diet in disease prevention.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- A study by researchers in Italy is focusing on the role of diet in preventing breast cancer. The rapid increase in the knowledge of breast cancer determinants and the continuing increase in...

Study: Breast-conserving surgery viable option for cancer involving nipple/areola.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- For many years, breast-conserving surgery has been the standard of care for women with early stage breast cancer. However, women with cancers involving the nipple and areola often are not given...

Study: Patients switched to AROMASIN more likely to remain cancer-free.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Postmenopausal breast cancer patients who switched from tamoxifen to AROMASIN (exemestane tablets) had a significantly reduced chance of recurrence and increased disease-free survival compared to...

Survival rates same for conservation treatment or mastectomy for recurrent DCIS.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Women who have a type of early breast cancer that is confined to the milk ducts have an equally good chance of successful recovery if the cancer recurs, regardless of how they were treated initially,...

Teenager's poetry booklet helps children cope with mothers' breast cancer.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The Breast Cancer Care & Research Fund (BCCRF) has been overwhelmed by requests for its poetry booklet "The Road to Communication Through Poetry of Healing," written by teenager Asha Mansukhani. ...

Treatment of ductal carcinoma in situ varies widely in United States.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- A new study has found that treatment of ductal carcinoma in situ (DCIS), a group of abnormal cells confined to the breast ducts, varies widely in the United States. Treatment ranges from potential...

Tumor characteristics may help predict survival.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- An 11-year study of breast cancer patients who had tumors removed but had no evidence of cancer in their lymph nodes has confirmed that certain factors may predict cancer recurrence, and help physicians...

Younger survivors suffer more long-term after effects.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- There's a growing need for special programs to be tailored to the needs of long-term cancer survivors. Younger women who survive breast cancer have particular problems in coping with the physical...

Thymidylate synthase mRNA predicts shorter survival in breast cancer.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The expression of thymidylate synthase mRNA is associated with shorter survival in patients with breast cancer. "Thymidine phosphorylase (TP), thymidylate synthase (TS) and dihydropyrimidine...

$1.7M award for cardiac safety monitoring and services announced.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT) has been awarded studies totaling approximately $1.7 million in cardiac safety monitoring and services from a top 15 global pharmaceutical organization under a...

Biotechnology company announces series B financing and new appointments.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Phylogix, Inc., announced that that it has secured $12 million in series B financing. Leading the round were top-tier venture capital firms Radius Ventures, Atlas Venture, Prospect Venture Partners,...

FluMist maker announces plan to achieve $2 billion in revenues by 2009.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced that it expects to achieve $2 billion in total revenues by 2009, driven by investments in its pipeline and the continued growth of its currently marketed products. ...

Lymphoseek maker reports annual revenue increase of 32%.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Neoprobe Corp. (NEOP) announced financial results for the fourth quarter of 2003 and for the full year that ended December 31, 2003. Results for the fourth quarter and for the full year of 2003...

Scripps Research Institute plans Florida research hospital.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The Scripps Research Institute plans to bring a 200-bed research hospital to northern Palm Beach County, Florida, to speed the process of turning research into new treatments for cancer, heart disease,...

Commercial agreement announced for cancer vaccine product candidate.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Prima BioMed Ltd, subsidiary CancerVac, and Biomira Inc. (BIOM) announced a commercial agreement for the development and commercialization of CancerVac's most advanced cancer vaccine product candidate....

Breast cancer gene carriers not at greater risk of relapse.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Carrying the highly aggressive BRCA breast cancer genes does not appear to be a risk factor for local relapse after treatment. This is puzzling, Suzette Delaloge, an assistant professor in the...

Diagnostic tool enables analysis of molecular characteristics of breast tumors.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Significant progress towards identifying the genetic make-up of individual tumors, hence allowing treatment choices to be made based on personalized information, was announced at the 4th European Breast...

Metastases share similar genetic profile to primary breast cancer tumor.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Work by scientists in The Netherlands contradicts the notion that breast cancer metastases behave differently than their primary tumors. Doctoral student Britta Weigelt told the meeting of the 4th...

Angiogenic cytokine and endostatin levels are linked in breast cancer patients.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Angiogenic cytokine and endostatin levels are linked in breast cancer patients. According to recent research from the Peoples Republic of China, "serum vascular endothelial growth factor (VEGF) and...

Pharmaceutical plant workers have no excess mortality.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- A study of pharmaceutical plant employees found no pattern of excess mortality over a 50-year period. "An historical cohort study was conducted of workers at a pharmaceutical manufacturing plant....

The Behavioral Oncology Interest Group reports on their annual meeting.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Behavioral approaches to cancer prevention are important but future efforts need to develop more integrative conceptual models, researchers say. According to published research from the United...

Radiation after prostate cancer recurrence benefits high-risk patients.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- A recurrence of cancer after a diseased prostate is removed is not necessarily as dire as doctors once believed, and radiation could save the lives of many men with such a condition, a study found. ...

'Young'-type breast tissue in older women can thwart breast cancer detection.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Many of today's generation of postmenopausal women have breast tissue more akin to that of younger women. This makes it harder for mammograms to pick up tumors or early signs of breast cancer in some...

Company receives approval for Paxene in Europe.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- IVAX Corp. (IVX) received approval from the European Commission for the extension of indication of the existing marketing authorization for IVAX's proprietary injectable paclitaxel (Paxene) to include...

Electric pulses show promise for healing or killing unhealthy cells.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- A new technology that uses electric fields to alter the "guts" of a cell may lead to improved methods of treating diseases such as cancer and leukemia, according to researchers in the University of...

Genetronics engages CRO for U.S. and European clinical trials.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Genetronics BioMedical Corp. (GEB) has contracted Quintiles Transnational Corp., a global pharmaceutical services organization, as the clinical research organization (CRO) for Genetronics' clinical...

New peptide conjugates could specifically target tumor vessel endothelial cells.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- New peptide conjugates could specifically target tumor vessel endothelial cells. "The NGR/alpha1,3Gal-HSA peptide was designed to specifically target CD13 positive cells and induce cell lysis. NGR...

Nurses recognize and try to meet psychological needs of chemotherapy patients.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Nurses find that patients need more psychological support at the beginning and end of chemotherapy treatment. "This study explored the perceptions of a group of registered oncology nurses about the...

Renal cancer human trial of phenoxodiol in combination therapy begins.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Marshall Edwards, Inc., (MSHL) has commenced a study that will test the ability of its investigational anticancer drug, phenoxodiol, to enhance the effect of platinum drugs in patients with solid...

Researcher developing tumor identification system for surgery.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- When removing a cancer tumor, doctors often must cut into healthy tissue to make sure they have removed all of the cancerous cells. While this is acceptable when a tumor is lodged in a leg, tumors that...

Study evaluates the 2-week wait rule for cancer referral in the U.K.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- General practitioners in the UK are mostly satisfied with the 2-week wait rule for cancer referral, but some had problems with the different forms required for referral. According to recent...

Valproic acid impedes angiogenesis in laboratory assays and study models.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Valproic acid impedes angiogenesis in laboratory assays and study models. According to recent research published in the journal Molecular Pharmacology, "valproic acid (VPA) is a widely used...

XR5967 alters tumor cell invasion and angiogenesis in vitro.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- XR5967 alters tumor cell invasion and angiogenesis in vitro. According to a study from England, "recent reports suggest that elevated levels of plasminogen activator inhibitor (PAI)-1 may...

Role of ABCA1 in cholesterol metabolism reviewed.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- The role of ABCA1 in cholesterol metabolism has been reviewed. "The ATP-binding cassette transporter A1 (ABCA1) is involved in the regulation of cholesterol efflux from cells," scientists in...

Parents of young adults with cancer need to interact with health professionals.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Parents of young adults with cancer need to be involved with health professionals caring for their children. A study from England, "examines the relationship between medical professionals and...

CDH1 and CDH13 methylation is a marker for more aggressive cervical cancer.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Researchers find that cervical cancer patients with unmethylated CDH1/CDH13 had better disease-free survival. "Cervical cancer is the principal cause of death due to cancer in women. Five-year...

ThinPrep launched at Pacific Rim Pathology Laboratory.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Cytyc Corporation (CYTC) announced that Pacific Rim Pathology Laboratory in San Diego, California, has implemented the ThinPrep Imaging System. Pacific Rim has been offering the ThinPrep Pap Test...

Aloxi injection incorporated into NCCN antiemetic guidelines.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- MGI Pharma, Inc., (MOGN) announced that Aloxi (palonosetron hydrochloride) injection has been incorporated into the 2004 National Comprehensive Cancer Network (NCCN) antiemetic guidelines for prevention...

Preliminary results of Xcytrin for chronic lymphocytic leukemia announced.
April 6, 2004... 2004 APR 6 - (NewsRx.com & NewsRx.net) -- Pharmacyclics, Inc., (PCYC) announced the presentation of preliminary results from its ongoing, recently initiated, phase II trial evaluating Xcytrin (motexafin gadolinium) Injection as a single agent...